Stockboy: They even got our address wrong!
++++++++++++++++++++++++++++++++++++
Senecio News & Publications
President of Senecio Software Inc. to Design and Coordinate DNA Phenomics' Bioinformatics and Web-based Research Initiatives
DNA Phenomics Appoints Dr. Jerry W. Wicks, Chief Technology Officer
KUALA LUMPUR, Malaysia – February 25, 2004 - DNA Phenomics, a biotech company focused on the emerging field of phenomics and the development of genomic-based diagnostic tests and drug discovery, announces that Dr. Jerry W. Wicks will become Chief Technology Officer (CTO), coordinating the company's bioinformatic plan including cluster computing design, data storage, statistical analysis systems, corporate communication technology, data gathering protocols, and software selection.
"Dr. Wicks brings an unusually diverse background and knowledge of statistical packages, hardware systems, software design, and electronic commerce to the CTO position at DNA Phenomics," said Chief Operating Officer, Ezehan Kamaluddin. "As we move into the emerging market of personalized medicine – a market defined by a variety of information and Internet-related technologies – it is essential we have an experienced technologist and scientist like Dr. Wicks to help us achieve our long term objectives. We agreed it was to both our advantages having Dr. Wicks remain President of Senecio Software. This arrangement makes it easier to draw upon that company's development and engineering experience," said Mr. Kamaluddin. "In many ways it is as though DNA Phenomics now has its own software division with all of the talent, resources, and engineering knowledge of that company immediately at hand."
Dr. Shaharuddin Datuk Aziz, DNA Phenomics' Chief Scientific Officer, noted, "Dr. Wicks' decades-long teaching experience at the graduate level in demographic methods, statistical packages, and survey research techniques will be invaluable to us as we implement our clinical genomics protocols, PhenoKit discovery platform, and planned personalized medicine field units. We will draw upon and use all of that experience."
"The opportunities available to DNA Phenomics in the Asia-Pacific region are boundless," said Dr. Wicks. "DNA Phenomics' business plan, world class scientific and management teams, and the growing number of alliances suggest DNA Phenomics could soon achieve a dominant position in the market. Accepting the CTO position was an easy decision for me to make in light of this young company's strengths and its potential for exponential growth."
Dr. Wicks is President and co-founder of Senecio Software Inc., a US-based corporation specializing in the design and production of advanced multi-tier, web-based applications. Dr. Wicks is Professor Emeritus at Bowling Green State University and Adjunct Professor of e-Commerce at the Helsinki School of Economics and Business Administration. For well over two decades, Dr. Wicks conducted research in the areas of population studies, survey research, and software design. As Director of Bowling Green State University's demographic and survey research center, he directed several hundred state, national, and international research projects. His teaching included graduate seminars in applied demography, statistical packages, survey research methods, and computers and society. He teaches the seminar in e-Commerce at the Helsinki School of Economics and Business Administration and regularly serves on scientific review panels at NIH. As co-founder of Senecio Software in 1992, his efforts and those of his colleagues have been directed largely at automating and refining Internet-based, large-scale data collection efforts using an array of web-related software
About DNA Phenomics Sdn Bhd
DNA Phenomics is a development-stage company focused on the emerging field of phenomics and the development of genomic-based diagnostic tests and drug discovery. The company's phenomics discovery platform offers university labs as well as pharmaceutical and life science companies a powerful research tool for uncovering patterns in the genome associated with health factors and drug responses. The company's goal is to become a leader in the discovery, development, and sale of genomic-based diagnostic healthcare products, pharmaceuticals, and biotech research services throughout Asia and the Pacific. Founded in 2003, DNA Phenomics is headquartered in Kuala Lumpur, Malaysia. DNA Phenomics is a privately-held company. Additional information about DNA Phenomics and its genomic-based solutions can be found at www.DNAphenomics.com.
Public Relations Contacts
Corporate Headquarters
Ezehan Reza Kamaluddin
Chief Operating Officer
28-1, Level 1, Jalan 28/70A
Desa Sri Hartamas
Kuala Lumpur, Malaysia
ezehan@dnaphenomics.com
+++++++++++++++++++++++++++++
I'm bemuddled
Stakddek
AI
